House Hearing, 92nd Congress - Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
House of Representatives, Congress."
House Hearing, 92nd Congress
- Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971.. Government. U.S. Government Publishing Office https://www.govinfo.gov/app/details/CHRG-92hhrg64533O.
APA
House of Representatives, Congress. (1971, June 10). House Hearing, 92nd Congress - Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971.. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/CHRG-92hhrg64533O
MLA
House of Representatives, Congress. House Hearing, 92nd Congress - Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971.. U.S. Government Publishing Office, (10 Jun 1971), https://www.govinfo.gov/app/details/CHRG-92hhrg64533O
Bluebook
House of Representatives, Congress, Notification of initiation or discontinuance of drug manufacture: hearing before the Subcommittee on Public Health and Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-second Congress, first session, on H.R. 4749 and H.R. 8963, bills to amend the Federal Food, Drug, and Cosmetic Act to provide for a current listing of each drug manufactured, prepared, propagated, compounded, or processed by a registrant under that Act, and for other purposes, June 10, 1971., GovInfo, (June 10, 1971), https://www.govinfo.gov/app/details/CHRG-92hhrg64533O